Friday, March 9, 2007

Research Grants to be made in Bradley's Memory

In my latest conversation with Bruce Shriver, he explained that the grants funded through our efforts will be made in Bradley's name. This means that when a cancer research facility receives a research grant that has been funded using the money we raise (as denoted by a memo line of the checks reading "Liddy Shriver Sarcoma Initiative/Bradley"), the doctors involved will know that this funding came from the hearts of those of us who knew and loved Bradley Paul Rice. The thought brought tears to my eyes. Here is a sample of how past grants have been awarded in this way:

The following is quoted from The Liddy Shriver Sarcoma Initiative website

December 2006 — The Liddy Shriver Sarcoma Initiative is pleased to announce the funding of two research projects at the Huntsman Cancer Institute at the University of Utah. The two grants, totaling $50,000, are being made in memory of Liddy Shriver, Brian Morden, Krystle Smith, Shane Duffy, Conor O'Sullivan, Paul Onvlee, and Allen Strehlow and to honor those currently fighting this disease. Both of the studies will be directed by Stephen Lessnick, M.D., Ph.D. at the Huntsman Cancer Institute. The ultimate goal of the first study, “New Approaches for EWS/ETS Detection in Ewing’s Sarcoma” is to improve physicians’ abilities to provide an accurate diagnosis of Ewing’s sarcoma to patients, to provide physicians’ with molecular data which may be relevant to prognosis, and to provide a new non-invasive assay for the measurement of treatment response. The goal of the second study, “Analysis of NR0B1 in Ewing’s sarcoma” is to help to characterize the molecular mechanisms involved in Ewing’s sarcoma development. Additionally, by fully understanding these mechanisms, Dr. Lessnick and his team hope to identify new therapeutic approaches for patients with this devastating disease. These grants were made possible because a number of people worked very hard in obtaining donations to sponsor much needed sarcoma research.

No comments: